Last reviewed · How we verify
NCT03142737
Are the "ounce-equivalents" in the Protein Foods Groups Really Equivalent?
NA trial testing Red kidney bean intake in Protein Metabolism in 45 participants. Completed in 15 May 2019.
6 March 2018
Quick facts
| Lead sponsor | University of Arkansas |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 45 |
| Start date | 8 May 2017 |
| Primary completion | 6 March 2018 |
| Estimated completion | 15 May 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Red kidney bean intake
- Eggs intake
- Peanut butter intake
- Ground beef intake
- Intact beef intake
Conditions studied
- Protein Metabolism — all drugs for Protein Metabolism →
Sponsor
University of Arkansas
Who can join
Adults 20 to 40, any sex, with Protein Metabolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will determine effects of different sources of protein on whole-body net protein synthesis and muscle protein synthesis in young healthy participants.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03142737
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Protein Metabolism
Currently open trials in the same condition.
- NCT07317921 — Validating IAAO for Muscle Outcomes · NA · recruiting
- NCT07020741 — Stable Isotopes- Adults With Obesity · NA · recruiting
- NCT07258576 — Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise · NA · recruiting
- NCT07148908 — Animal and Microbial-based Dietary Protein Efficiency in Adults · NA · recruiting
Other University of Arkansas trials
Trials by the same sponsor.
- NCT07029776 — MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma · Phase 2 · not yet recruiting
- NCT07341399 — Essential Amino Acid Supplementation in Adult Spinal Deformity Patients · NA · not yet recruiting
- NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT06604065 — Essential Amino Acids and Parkinsons Disease · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03142737 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Arkansas
- Last refreshed: 3 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03142737.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing